Kyocera Medical Technologies, Inc. Sustainability Profile
Kyocera Medical Technologies, Inc., a subsidiary of Kyocera Corporation, is a leading player in the medical device industry, headquartered in the United States. Established in 1985, the company has made significant strides in developing innovative solutions for orthopaedic and spinal surgery, focusing on advanced materials and cutting-edge technology. With a strong presence in North America and expanding operations globally, Kyocera Medical Technologies is renowned for its core products, including ceramic implants and surgical instruments. These offerings are distinguished by their biocompatibility and durability, setting new standards in patient care. The company has achieved notable recognition for its commitment to quality and innovation, positioning itself as a trusted partner in the healthcare sector. Through continuous research and development, Kyocera Medical Technologies remains at the forefront of medical advancements, dedicated to improving surgical outcomes and enhancing patient quality of life.
DitchCarbon Score
How does Kyocera Medical Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kyocera Medical Technologies, Inc.'s score of 47 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kyocera Medical Technologies, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Kyocera Corporation, which cascades its climate commitments and emissions data down to its subsidiaries. Kyocera Corporation has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Kyocera Medical Technologies, Inc. have not been disclosed. As a part of its corporate family, Kyocera Medical Technologies, Inc. aligns with the broader sustainability goals of Kyocera Corporation, which focuses on reducing its overall carbon footprint and enhancing environmental responsibility. The absence of specific emissions data highlights the need for ongoing transparency and commitment to climate action within the medical technology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | - | - |
| Scope 2 | - | - | - | - | - | - | - | - | - |
| Scope 3 | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Kyocera Medical Technologies, Inc.'s Industry?
How Carbon Intensive is Kyocera Medical Technologies, Inc.'s Location?
Kyocera Medical Technologies, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Kyocera Medical Technologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
